Solventum Corporation logo

Solventum Corporation

SOLV | NYSE
Chart Builder DCF Calculator
$88.75
-$0.09 (-0.10%)
Sep 22, 2026, 4:00 PM ET · Market open
-0.10%

Rating

Updated: Aug 17, 2026
64.7
Fundamentals Strong
Market Sentiment Bullish
Moat Narrow

Key Statistics

Market Data

Market Cap $15.37B
1D Range
88.48 89.42
52W Range
62.38 94.16

Valuation (TTM)

PE 10.85
PB 3.21
EV/EBITDA 7.80

Valuation (NTM)

Forward PE 12.26
Forward PEG 5.41
Price Target $91.22
Loading financial charts...

Profile

Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that ad...

Sector Healthcare
Employees 20,584
IPO Date Mar 31, 2024
Fiscal Year January - December

Latest News

Solventum: Divestiture Unlocking Upside In A Spinoff Revaluation Play

6 days ago · seekingalpha.com

Solventum: Divestiture Unlocking Upside In A Spinoff Revaluation Play
Here's Why You Should Hold Solventum Stock in Your Portfolio for Now

7 days ago · zacks.com

Here's Why You Should Hold Solventum Stock in Your Portfolio for Now
Here's Why Solventum (SOLV) is a Strong Value Stock

7 days ago · zacks.com

Here's Why Solventum (SOLV) is a Strong Value Stock
Why Solventum (SOLV) is a Top Stock for the Long-Term

9 days ago · zacks.com

Why Solventum (SOLV) is a Top Stock for the Long-Term
Solventum Corporation (SOLV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

15 days ago · seekingalpha.com

Solventum Corporation (SOLV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Solventum (SOLV) Up 11.4% Since Last Earnings Report: Can It Continue?

20 days ago · zacks.com

Solventum (SOLV) Up 11.4% Since Last Earnings Report: Can It Continue?
Solventum to Participate in the 2026 Wells Fargo Healthcare Conference

22 days ago · prnewswire.com

Solventum to Participate in the 2026 Wells Fargo Healthcare Conference
Should Investors Buy SOLV as Growth Improves but Debt Risks Persist?

22 days ago · zacks.com

Should Investors Buy SOLV as Growth Improves but Debt Risks Persist?
Earnings Growth & Price Strength Make Solventum (SOLV) a Stock to Watch

22 days ago · zacks.com

Earnings Growth & Price Strength Make Solventum (SOLV) a Stock to Watch
Solventum Corporation (NYSE:SOLV) Receives Average Recommendation of “Moderate Buy” from Brokerages

23 days ago · defenseworld.net

Solventum Corporation (NYSE:SOLV) Receives Average Recommendation of “Moderate Buy” from Brokerages

Earnings

Next Earnings
Nov 5, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
8
Consensus
Buy
Price Target
$95
Upside
+7.04%
Buy (7)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.